Atlas Trials

Ledipasvir/Sofosbuvir Fixed-Dose Combination in Adults With Nosocomial Genotype 1 HCV Infection

Clinical trial NCT01924949 · COMPLETED

Trial details

NCT number
NCT01924949
Sponsor
Gilead Sciences
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatitis C
Start date
2013-07-01
Primary completion
2014-05-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.